A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples